AAO 2024: NMA reveals Vabysmo’s superior CST improvement over Eylea HD
This NMA serves to bridge the gap between trials for both therapies and compare them to one another based on existing data.
This NMA serves to bridge the gap between trials for both therapies and compare them to one another based on existing data.
What's Your Reaction?
